Anon-catalytic,mild, and easy-to-handle protecting group switched 1,3-dipolar cycloaddition (1,3-DC) between bior mono-N-protected Dha and C,N-cyclic azomethine imines, which affordv arious quaternary amino acids with diverse scaffolds,i sd isclosed. Specifically,n ormal-electron-demand 1,3-DC reaction occurs between biN protected Dha and C,Ncyclic azomethine imines,w hile inverse-electron-demand 1,3-DC reaction occurs between mono-N-protected Dha and C,Ncyclic azomethine imines.A bove all, the reactions can be carried out between peptides with Dha residues at the position of interest and C,N-cyclic azomethine imines,both in homogeneous phase and on resins in SPPS.I tp rovides an ew toolkit for late-stage peptide modification, labeling,and peptide-drug conjugation. To shed light on the high regioselectivity of the reaction, DFT calculations were carried out, which were qualitatively consistent with the experimental observations.
The
development of antimicrobial compounds is now regarded as an
urgent problem. Antimicrobial peptides (AMPs) have great potential
to become novel antimicrobial drugs. Feleucin-K3 is an α-helical
cationic AMP isolated from the skin secretion of the Asian bombinid
toad species Bombina orientalis and has antimicrobial
activity. In our previous studies, amino acid scanning of Feleucin-K3
was performed to determine the key site affecting its activity. In
this study, we investigated and synthesized a series of analogues
that have either a natural or an unnatural hydrophobic amino acid
substitution at the fourth amino acid residue of Feleucin-K3. Among
these analogues, Feleucin-K59 (K59), which has an α-(4-pentenyl)-Ala
substitution, was shown to have increased antimicrobial activity against
both standard and drug-resistant strains of clinical common bacteria,
improved stability, no hemolytic activity at antimicrobial concentrations,
and no resistance. In addition, K59 has potent antibiofilm activity in vitro. More importantly, K59 showed better antimicrobial
and antibiofilm activities against drug-resistant bacteria in in vivo experiments in mice than traditional antibiotics.
In this preliminary study of the mechanism of action, we found that
K59 could rapidly kill bacteria by a dual-action mechanism of disrupting
the cell membrane and binding to intracellular DNA, thus making it
difficult for bacteria to develop resistance.
The antimicrobial peptide APKGVQGPNG (named YD), a natural peptide originating from
Bacillus amyloliquefaciens
CBSYD1, exhibited excellent antibacterial and antioxidant properties
in vitro
. These characteristics are closely related to inflammatory responses which is the central trigger for liver fibrosis. However, the therapeutic effects of YD against hepatic fibrosis and the underlying mechanisms are rarely studied. In this study, we show that YD improved liver function and inhibited the progression of liver fibrosis by measuring the serum transaminase activity and the expression of
α
-smooth muscle actin and collagen I in carbon tetrachloride-induced mice. Then we found that YD inhibited the level of miR-155, which plays an important role in inflammation and liver fibrosis. Bioinformatics analysis and luciferase reporter assay indicate that
Casp12
is a new target of miR-155. We demonstrate that YD significantly decreases the contents of inflammatory cytokines and suppresses the NF-
κ
B signaling pathway. Further studies show that transfection of the miR-155 mimic in RAW264.7 cells partially reversed the YD-mediated CASP12 upregulation, the downregulated levels of inflammatory cytokines, and the inactivation of the NF-
κ
B pathways. Collectively, our study indicates that YD reduces inflammation through the miR-155–
Casp12
–NF-
κ
B axis during liver fibrosis and provides a promising therapeutic candidate for hepatic fibrosis.
The dramatic increase in antimicrobial resistance (AMR) highlights an urgent need to develop new antimicrobial therapies. Thus, antimicrobial peptides (AMPs) have emerged as promising novel antibiotic alternatives. Feleucin-K3 is an amphiphilic α-helical nonapeptide that has powerful antimicrobial activity. In our previous study, it was found that the fourth residue of Feleucin-K3 is important for antimicrobial activity. After α-(4-pentenyl)-Ala was introduced into this position, both the antimicrobial activity and stability were greatly improved. Herein, to improve the limitations of Feleucin-K3, this unnatural amino acid was further introduced into different positions of Feleucin-K3. Among these synthetic Feleucin-K3 analogs, the N-terminal-substituted analog Feleucin-K65 (K65) and C-terminal-substituted analog Feleucin-K70 (K70) had preferable antimicrobial activity. In particular, their antimicrobial activities against multidrug-resistant bacteria were more potent than that of antibiotics. The stabilities of these peptides in salt and serum environments were improved compared with those of Feleucin-K3. In addition, these analogs had low hemolytic activity and AMR. More importantly, they effectively inhibited biofilm formation and exhibited considerable efficacy compared with traditional antibiotics against biofilm infection caused by methicillin-resistant Staphylococcus aureus (MRSA). In antimicrobial mechanism studies, K65 and K70 mainly permeated the outer membrane and depolarized the cytoplasmic membrane, resulting in cellular component leakage and cell death. In summary, analogs K65 and K70 are potential antimicrobial alternatives to solve the antibiotic crisis.
The prevalence of multidrug-resistant bacterial infections has
led to dramatically increased morbidity and mortality. Antimicrobial
peptides (AMPs) have great potential as new therapeutic agents to
reverse this dangerous trend. Herein, a series of novel AMP Feleucin-K3
analogues modified with unnatural peptidomimetic sulfono-γ-AA
building blocks were designed and synthesized. The structure–activity,
structure–toxicity, and structure–stability relationships
were investigated to discover the optimal antimicrobial candidates.
Among them, K122 exhibited potent and broad-spectrum antimicrobial
activity and high selectivity. K122 had a rapid bactericidal effect
and a low tendency to induce resistance. Surprisingly, K122 showed
excellent effectiveness against bacterial pneumonia. For biofilm and
local skin infections, K122 significantly decreased the bacterial
load and improved tissue injury at a dose of only 0.25 mg/kg, which
was 160 times lower than the concentration deemed to be safe for local
dermal applications. In summary, K122 is an outstanding candidate
for the treatment of multidrug-resistant bacteria and biofilm infections.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.